Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients

被引:60
|
作者
Ding, Yi [1 ]
Chen, Bin [2 ]
Wang, Shuang [3 ]
Zhao, Liang [3 ]
Chen, Juanzhi [3 ]
Ding, Yanqing [3 ]
Chen, Longhua [1 ]
Luo, Rongcheng [2 ]
机构
[1] So Med Univ, Dept Radiat Oncol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[2] So Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[3] So Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; Tiam1; expression; immunohistochemical analysis; prognosis; NUCLEOTIDE EXCHANGE FACTORS; RHO GTPASES; GENE; RAC; EXPRESSION; PROTEIN; ACTIVATION; ONCOGENE; SURVIVAL; ADHESION;
D O I
10.1002/ijc.23954
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Little research has been done to test the usefulness of T-lymphoma invasion and metastasis 1 (Tiam1) as a prognostic marker for hepatocellular carcinoma (HCC). In this study, we investigated Tiam1 expression and its prognostic value for HCC. HCC surgical tissue samples were taken from 152 HCC patients who had been followed up for 5 years. Overexpression of Tiam1 (Tiam1 2+ to 3+) was shown in 63.8% of the cases. The Tiam1 expression level did not correlate with any clinicopathological parameters. However, survival analysis showed that the Tiam1 overexpression group had a significantly shorter overall survival time than the Tiam1 downexpression group (p = 0.008). Multivariate analysis showed that Tiam1 expression was a significant and independent prognostic parameter (p = 0.042) for HCC patients. Tiam1 expression may be a novel and independent predictor for the prognosis of HCC patients. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:653 / 658
页数:6
相关论文
共 50 条
  • [1] Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma
    Liu, Huaimin
    Shi, Guirong
    Liu, Xiaoli
    Wu, Hui
    Fan, Qinxia
    Wang, Xin
    ONCOLOGY REPORTS, 2011, 25 (03) : 841 - 848
  • [2] Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
    Jian Ruan
    Haiyan Zheng
    Xiaodong Rong
    Xiaomin Rong
    Junyi Zhang
    Weijia Fang
    Peng Zhao
    Rongcheng Luo
    Molecular Cancer, 15
  • [3] Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
    Ruan, Jian
    Zheng, Haiyan
    Rong, Xiaodong
    Rong, Xiaomin
    Zhang, Junyi
    Fang, Weijia
    Zhao, Peng
    Luo, Rongcheng
    MOLECULAR CANCER, 2016, 15
  • [4] Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Jiang, Jie
    Liu, Bin
    Liu, Ruilin
    Yang, Wenzhuo
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2517 - 2537
  • [5] Clinical implication of Tiam1 overexpression in the prognosis of patients with serous ovarian carcinoma
    Li, Huiwen
    Cui, Xuelian
    Chen, Dingbao
    Yang, Yang
    Piao, Junjie
    Lin, Zhenhua
    Yan, Guanghai
    Shen, Danhua
    ONCOLOGY LETTERS, 2016, 12 (05) : 3492 - 3498
  • [6] FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
    Wang, Yan
    Sun, Mengjing
    Liu, Jibin
    Liu, Ying
    Jiang, Chunyi
    Zhu, Huijun
    Wang, Wei
    Wang, Yao
    ONCOLOGY LETTERS, 2020, 19 (01) : 795 - 804
  • [7] Up-regulation of Tiam1 and Rac1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
    Yang, Wanyong
    Lv, Shemin
    Liu, Xingyan
    Liu, Hong
    Yang, Wen
    Hu, Fu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1053 - 1059
  • [8] Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
    Liu, Shuguang
    Li, Yumei
    Qi, Wenjuan
    Zhao, Yunfei
    Huang, Aili
    Sheng, Wenjie
    Lei, Bin
    Lin, Peixin
    Zhu, Haili
    Li, Wenxia
    Shen, Hong
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [9] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [10] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    Medical Oncology, 2013, 30